The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
淋巴细胞/单核细胞比值可预测伊沙妥昔单抗联合泊马度胺治疗多发性骨髓瘤患者的疗效
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03711-8
Shimazu, Yutaka; Kanda, Junya; Onda, Yoshiyuki; Fuchida, Shin-Ichi; Ohta, Kensuke; Shimura, Yuji; Kosugi, Satoru; Yamamura, Ryosuke; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Adachi, Yoko; Anzai, Naoyuki; Hotta, Masaaki; Fukushima, Kentaro; Yagi, Hideo; Yoshihara, Satoshi; Tanaka, Yasuhiro; Takakuwa, Teruhito; Tanaka, Hirokazu; Shibayama, Hirohiko; Uoshima, Nobuhiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Matsumura, Itaru; Kuroda, Junya; Takaori-Kondo, Akifumi; Hino, Masayuki